Letter
PPIs with clopidogrel
Evidence of net benefit of proton pump inhibitors with clopidogrel is lacking in older patients
Cite this as:
BMJ
2012;345:e5849
- Miles D Witham, senior lecturer in ageing and health1,
- Roy Soiza, clinical senior lecturer and consultant geriatrician2,
- Ian Logan, specialist registrar in medicine for the elderly3
- 1University of Dundee, Ageing and Health, Ninewells Hospital, Dundee DD1 9SY, UK
- 2University of Aberdeen, Aberdeen Royal Infirmary, Aberdeen, UK
- 3NHS Tayside, Ninewells Hospital
- m.witham{at}dundee.ac.uk
Although proton pump inhibitor (PPI) use was not associated with increased risk of myocardial infarction in people on dual antiplatelet treatment,1 we are worried by the linked editorial’s suggestion that PPIs should therefore be prescribed to a wide range of patients on this treatment.2
PPIs have …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking